Why Is $7B Valued Cancer Focused Exelixis (EXEL) Trading Lower Today? – Exelixis (NASDAQ:EXEL)
Sunday, Exelixis Inc EXEL provided financial guidance for fiscal year 2024 and delivered an update on its business. The company announced preliminary FY23 revenue of $1.83 billion versus the consensus of $1.84 billion,…